In this context, angiotensin-converting enzyme (ACE) inhibitors (ACEIs), such as lisinopril and captopril, and putative biopeptides are medications used to manage hypertension, heart failure, and kidney diseases like diabetic nephropathy (Ahmad et al., 2023). This evidence concerns the gene ACE and kidney disorder.